Ahmedabad, India – April 17, 2025 – AI4Pharma, a emerging innovator in pharma-specific AI solutions, proudly announces the launch of ChatGMP, a domain-trained conversational platform built exclusively for pharmaceutical teams working in GMP-regulated environments.
Unlike generic chatbots, ChatGMP is designed from the ground up to understand the language, compliance requirements, and operational nuances of pharma teams — enabling smarter, faster, and compliant communication across departments.
ChatGMP aggregates inspection data from multiple FDA sources, competitor profiles, and historical compliance records. No more jumping across websites or manually pulling data—everything is in one place.
Have a question like “What were the top FDA 483 observations in the last year for sterile facilities?”? Just ask ChatGMP. The platform understands complex queries and returns structured, contextual answers.
ChatGMP doesn’t just provide data—it helps you analyze it. Identify trends, flag risk areas, and compare competitor performance across geographies or product types.
By automating data gathering and simplifying analysis, ChatGMP slashes the time it takes to make critical compliance decisions.
“The launch of ChatGMP marks a significant milestone in our mission to harness AI for better Pharma outcomes,” said Mr. Amish Vyas, Co-Founder & CEO at AI4Pharma. “We’re excited to offer a solution that not only streamlines communication but also upholds the highest standards of accuracy and compliance.
Ai4Pharma is backed by Silver Touch Technologies, a well-established IT services company with over 28+ years if experience in technology and software development. Silver Touch Technologies is publicly listed in India and operates globally, with a presence in India, USA, UK, Canada. With a team of over 1400+ IT professionals, Silver Touch's vast expertise and global reach provide critical support in helping Ai4Pharma accelerate its mission.
For more information about ChatGMP and AI4Pharma’s suite of solutions, Connect with us.